BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DiStefano TJ, Vaso K, Danias G, Chionuma HN, Weiser JR, Iatridis JC. Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations. Adv Healthc Mater 2022;11:e2100596. [PMID: 34297485 DOI: 10.1002/adhm.202100596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Wu Y, Tan G, Xu Z, Xue H. Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration. Front Pharmacol 2022;13:992476. [DOI: 10.3389/fphar.2022.992476] [Reference Citation Analysis]
2 Hao Y, Zhu G, Yu L, Ren Z, Zhang P, Zhu J, Cao S. Extracellular vesicles derived from mesenchymal stem cells confer protection against intervertebral disc degeneration through a microRNA-217-dependent mechanism. Osteoarthritis Cartilage 2022:S1063-4584(22)00827-5. [PMID: 36041665 DOI: 10.1016/j.joca.2022.08.009] [Reference Citation Analysis]
3 Yu X, Liu Q, Lu R, Wang S, Xu H, Wang Y, Bao Y, Jiang Y, Li M, Kang H, Kozlov AV. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying circ_0050205 Attenuate Intervertebral Disc Degeneration. Oxidative Medicine and Cellular Longevity 2022;2022:1-27. [DOI: 10.1155/2022/8983667] [Reference Citation Analysis]
4 Yu X, Xu H, Liu Q, Wang Y, Wang S, Lu R, Jiang Y, Kang H, Hu W, Diomede F. circ_0072464 Shuttled by Bone Mesenchymal Stem Cell-Secreted Extracellular Vesicles Inhibits Nucleus Pulposus Cell Ferroptosis to Relieve Intervertebral Disc Degeneration. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/2948090] [Reference Citation Analysis]
5 Qian J, Wang X, Su G, Shu X, Huang Z, Jiang H, Zhu Q. Platelet-rich plasma-derived exosomes attenuate intervertebral disc degeneration by promoting NLRP3 autophagic degradation in macrophages. Int Immunopharmacol 2022;110:108962. [PMID: 35753124 DOI: 10.1016/j.intimp.2022.108962] [Reference Citation Analysis]
6 Zhou ZM, Bao JP, Peng X, Gao JW, Vlf C, Zhang C, Sun R, Kun-Wang, Wu XT. Small extracellular vesicles from hypoxic mesenchymal stem cells alleviate intervertebral disc degeneration by delivering miR-17-5p. Acta Biomater 2022;140:641-58. [PMID: 34879291 DOI: 10.1016/j.actbio.2021.11.044] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hu S, Xing H, Zhang J, Zhu Z, Yin Y, Zhang N, Qi Y, Li YS. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Immunomodulatory Effects and Potential Applications in Intervertebral Disc Degeneration. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/7538025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lu L, Xu A, Gao F, Tian C, Wang H, Zhang J, Xie Y, Liu P, Liu S, Yang C, Ye Z, Wu X. Mesenchymal Stem Cell-Derived Exosomes as a Novel Strategy for the Treatment of Intervertebral Disc Degeneration. Front Cell Dev Biol 2022;9:770510. [DOI: 10.3389/fcell.2021.770510] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xia C, Dai Z, Jin Y, Chen P. Emerging Antioxidant Paradigm of Mesenchymal Stem Cell-Derived Exosome Therapy. Front Endocrinol (Lausanne) 2021;12:727272. [PMID: 34912294 DOI: 10.3389/fendo.2021.727272] [Reference Citation Analysis]